MarketCap
Facebook
X
TelegramGeschäftsbericht 2022
hinzugefügt 23.12.2023
HEXO Corp. Betriebszyklus 2011-2026 | HEXO
Betriebszyklus Jährlich HEXO Corp.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 775 | 451 | - | - | - | - | - |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 775 | 451 | 613 |
Betriebszyklus anderer Aktien in der Arzneimittelhersteller
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
16.5 | - | 7.5 % | $ 6.35 M |  USA |
 |
Agile Therapeutics
AGRX
|
146 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
181 | - | - | $ 142 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
121 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
576 | - | - | $ 754 M | USA |
 |
Cronos Group
CRON
|
425 | $ 2.64 | -1.12 % | $ 1.36 B |  Canada |
 |
DURECT Corporation
DRRX
|
560 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
214 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
180 | - | - | $ 28.9 M |  Irlanda |
 |
Harrow Health
HROW
|
217 | $ 40.9 | 0.91 % | $ 1.5 B | USA |
 |
Catalent
CTLT
|
152 | - | - | $ 11.5 B | USA |
 |
Athenex
ATNX
|
247 | - | -23.39 % | $ 1.76 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
614 | $ 4.36 | 4.06 % | $ 61.3 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
416 | - | - | $ 2.06 B |  France |
 |
Jupiter Wellness
JUPW
|
112 | - | - | $ 33.6 M | USA |
 |
Pacira BioSciences
PCRX
|
246 | $ 24.44 | -4.12 % | $ 1.13 B | USA |
 |
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | USA |
 |
Bausch Health Companies
BHC
|
78.9 | $ 5.65 | -1.22 % | $ 2.06 B | Canada |
 |
Canopy Growth Corporation
CGC
|
230 | $ 1.13 | 1.8 % | $ 122 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
182 | $ 1.2 | 9.09 % | $ 1.49 M | USA |
 |
Aurora Cannabis
ACB
|
1.45 K | $ 3.48 | 1.16 % | $ 86.3 M | Canada |
 |
Tilray
TLRY
|
222 | $ 6.16 | -1.28 % | $ 3.81 B | Canada |
 |
Lannett Company
LCI
|
210 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
2.92 K | $ 1.42 | 0.71 % | $ 402 M | Canada |
 |
Veru
VERU
|
271 | $ 2.26 | 0.44 % | $ 305 M | USA |
 |
Evolus
EOLS
|
134 | $ 5.33 | -1.11 % | $ 344 M | USA |
 |
Emergent BioSolutions
EBS
|
237 | $ 8.47 | 2.67 % | $ 434 M | USA |
 |
Organogenesis Holdings
ORGO
|
159 | $ 2.57 | 9.36 % | $ 338 M | USA |
 |
cbdMD
YCBD
|
176 | $ 0.87 | 0.14 % | $ 3.75 M | USA |
 |
ProPhase Labs
PRPH
|
141 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
220 | - | - | $ 1.42 B | USA |
 |
Assertio Holdings
ASRT
|
590 | $ 18.47 | 0.22 % | $ 118 M | USA |
 |
PetIQ
PETQ
|
108 | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
112 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
508 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
106 | $ 0.99 | 6.48 % | $ 49.4 M | USA |
 |
PLx Pharma
PLXP
|
111 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
219 | $ 15.04 | 0.67 % | $ 18.1 B | USA |
 |
Zomedica Corp.
ZOM
|
218 | - | -0.21 % | $ 98 M | USA |
 |
Rockwell Medical
RMTI
|
72.5 | $ 0.89 | 1.29 % | $ 32 M | USA |
 |
China Pharma Holdings
CPHI
|
187 | $ 0.53 | -2.39 % | $ 2.27 M |  China |
 |
TherapeuticsMD
TXMD
|
3.34 K | $ 2.07 | 1.47 % | $ 23.9 M | USA |